In vitro transepithelial drug transport by on-line measurement: Cellular control of paracellular and transcellular transport

Journal of Pharmaceutical Sciences

Volumn 88, Issue 12, 1999, Pages 1340-1347

  Wielinga, Peter R ^a   De Waal, Esther ^a   Westerhoff, Hans V ^a   Lankelma, Jan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN; DAUNORUBICIN; DIGITONIN; DILTIAZEM; FLUORESCEIN ISOTHIOCYANATE; FLUORESCENT DYE; IDARUBICIN; VALSPODAR; VERAPAMIL;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; DOG; DRUG TRANSPORT; EPITHELIUM CELL; NONHUMAN; TIGHT JUNCTION;

EID: 0032748841     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980497z     Document Type: Article

References (39)

1. Topp E. M. Barriers to delivery of macromolecules. Med. Chem. Res. 1997, 7, 493-508.
2. Hayashi M.; Tomita M.; Awazu S. Transcellular and paracellular contribution to transport processes in the colorectal route. Adv. Drug Deliv. Rev. 1997, 28, 191-204.
3. Lennernas H. Human intestinal permeability. J. Pharm. Sci. 1998, 87, 403-410.
4. Staddon J. M.; Rubin L. L. Cell adhesion, cell junctions and the blood-brain barrier. Curr. Opin. Neurobiol. 1996, 6, 622-627.
5. Cereijido M.; Valdes J.; Shoshani L.; Contreras R. G. Role of tight junctions in establishing and maintaining cell polarity. Annu. Rev. Physiol. 1998, 60, 161-177.
6. Mitic L. L.; Anderson J. M. Molecular architecture of tight junctions. Annu. Rev. Physiol. 1998, 60, 121-142.
7. Spring K. R. Routes and mechanism of fluid transport by epithelia. Annu. Rev. Physiol. 1998, 60, 105-119.
8. Koepsell H. Organic cation transporters in intestine, kidney, liver, and brain. Annu. Rev. Physiol. 1998, 60, 243-266.
9. Gottesman M. M.; Hrycyna C. A.; Schoenlein P. V.; Germann U. A.; Pastan I. Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 1995, 29, 607-649.
10. Germann U. A. P-glycoprotein - A mediator of multidrug resistance in tumour cells. Eur. J. Cancer 1996, 32A, 927-944.
11. Juliano R. L.; Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 1976, 455, 152-162.
12. Ford J. M. Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers. Eur. J. Cancer 1996, 32A, 991-1001.
13. Lee C. G. L.; Gottesman M. M.; Cardarelli C. O.; Ramachandra M.; Jeang K. T.; Ambudkar S. V.; Pastan I.; Dey S. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 1998, 37, 3594-3601.
14. Borst P.; Schinkel A. H. Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet. 1997, 13, 217-222.
15. Schinkel A. H. The physiological function of drug-transporting P-glycoproteins. Semin. Cancer. Biol. 1997, 8, 161-170.
16. van Asperen J.; Mayer U.; van Tellingen O.; Beijnen J. H. The functional role of P-glycoprotein in the blood-brain barrier. J. Pharm. Sci. 1997, 86, 881-884.
17. Adson A.; Burton P. S.; Raub T. J.; Barsuhn C. L.; Audus K. L.; Ho N. F. H. Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: Uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. J. Pharm. Sci. 1995, 84, 1197-1204.
18. Evers R.; Kool M.; van Deemter L.; Janssen H.; Calafat J.; Oomen L. C. J. M.; Paulusma C. C.; Elferink R. P. J. O.; Baas F.; Schinkel A. H.; Borst P. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J. Clin. Invest. 1998, 101, 1310-1319.
19. Madara J. L. Regulation of the movement of solutes across tight junctions. Annu. Rev. Physiol. 1998, 60, 143-159.
20. Mullin J. M.; Soler A. P.; Laughlin K. V.; Kampherstein J. A.; Russo L. M.; Saladik D. T.; George K.; Shurina R. D.; O'Brien T. G. Chronic exposure of LLC-PK1 epithelia to the phorbol ester TPA produces polyp-like foci with leaky tight junctions and altered protein kinase C-alpha expression and localization. Exp. Cell Res. 1996, 227, 12-22.
21. Wielinga P. R.; Heijn M.; Broxterman H. J.; Lankelma J. P-glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells. Biochem. Pharmacol. 1997, 54, 791-799.
22. Lankelma J.; Spoelstra E. C.; Dekker H.; Broxterman H. J. Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradient. Biochim. Biophys. Acta 1990, 1055, 217-222.
23. Wielinga, P. R.; Heijn, M.; Westerhoff, H. V.; Lankelma, J. A method for studying plasma membrane transport with intact cells using computerized fluorometry. Anal. Biochem. 1998, 263, 221-231.
24. Lankelma J.; Laurensse E.; Pinedo H. M. A flow-through tissue culture system with fast dynamic response. Anal. Biochem. 1982, 127, 340-345.
25. Bakos, E.; Evers, R.; Szakacs, G.; Tusnady, G. E.; Welker, E.; Szabo, K.; de Haas, M.; van Deemter, L.; Borst, P.; Varadi, A.; Sarkadi, B. Functional Multidrug Resistance Protein (MRP1) Lacking the N-terminal Transmembrane Domain. J. Biol. Chem. 1998, 273, 32167-32175.
26. Adson A.; Raub T. J.; Burton P. S.; Barsuhn C. L.; Hilgers A. R.; Audus K. L.; Ho N. F. H. Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. J. Pharm. Sci. 1994, 83, 1529-1536.
27. Stuart R. O.; Nigam S. K. Regulated assembly of tight junctions by protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 6072-6076.
28. Kovbasnjuk O. N.; Szmulowicz U.; Spring K. R. Regulation of the MDCK cell tight junction. J. Membr. Biol. 1998, 161, 93-104.
29. Stuart R. O.; Sun A.; Panichas M.; Hebert S. C.; Brenner B. M.; Nigam S. K. Critical role for intracellular calcium in tight junction biogenesis. J. Cell. Physiol. 1994, 159, 423-433.
30. Tomita M.; Hayashi M.; Awazu S. Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells. J. Pharm. Sci. 1996, 85, 608-611.
31. Mullin J. M.; Kampherstein J. A.; Laughlin K. V.; Clarkin C. E. K.; Miller R. D.; Szallasi Z.; Kachar B.; Soler A. P.; Rosson D. Overexpression of protein kinase C-delta increases tight junction permeability in LLC-PK1 epithelia. Am. J. Physiol. Cell. Physiol. 1998, 44, C544-C554.
32. Collaresbuzato C. B.; Mcewan G. T. A.; Jepson M. A.; Simmons N. L.; Hirst B. H. Paracellular barrier and junctional protein distribution depend on basolateral extracellular Ca2+ in cultured epithelia. Biochim. Biophys. Acta 1994, 1222, 147-158.
33. Lynch R. D.; Tkachukross L. J.; Mccormack J. M.; Mccarthy K. M.; Rogers R. A.; Schneeberger E. E. Basolateral but not apical application of protease results in a rapid rise of transepithelial electrical resistance and formation of aberrant tight junction strands in MDCK cells. Eur. J. Cell. Biol. 1995, 66, 257-267.
34. Citi S.; Denisenko N. Phosphorylation of the tight junction protein cingulin and the effects of protein kinase inhibitors and activators in MDCK epithelial cells. J. Cell. Sci. 1995, 108, 2917-2926.
35. Collaresbuzato C. B.; Jepson M. A.; Simmons N. L.; Hirst B. H. Increased tyrosine phosphorylation causes redistribution of adherens junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia. Eur. J. Cell. Biol. 1998, 76, 85-92.
36. Sakakibara A.; Furuse M.; Saitou M.; AndoAkatsuka Y.; Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. J. Cell. Biol. 1997, 137, 1393-1401.
37. Grundemann D.; Gorboulev V.; Gambaryan S.; Veyhl M.; Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994, 372, 549-552.
38. Skovsgaard T.; Nissen N. I. Membrane transport of anthracyclines. Pharm. Ther. 1982, 18, 293-311.
39. Smit J. W.; Weert B.; Schinkel A. H.; Meijer D. K. F. Heterologous expression of various P-glycoproteins in polarized epithelial cells induces directional transport of small (type 1) and bulky (type 2) cationic drugs. J. Pharmacol. Exp. Ther. 1998, 286, 321-327.